Bayer

The company runs a diversified, research‑driven life‑sciences model. It invests in discovery and development of pharmaceuticals, consumer health products and agricultural technologies, then commercialises them through global manufacturing, regulatory approval and distribution networks. Value is created by delivering clinically validated medicines, branded OTC products and crop‑science solutions that improve health outcomes and agricultural productivity. Acquisitions such as radiology AI platforms, e‑commerce‑focused supplement providers and oncology technology firms extend its product portfolio and technology base. Digital agriculture platforms aggregate and analyse field data to support agronomic decision‑making, reinforcing demand for the firm’s seeds and crop‑protection products and enabling bundled product‑and‑service offerings.

Bayer AG is a German life-sciences conglomerate active in pharmaceuticals, consumer health and crop science. It operates globally through subsidiaries, selling prescription medicines, over‑the‑counter healthcare products and agricultural inputs such as seeds and crop‑protection chemicals, plus associated digital farming platforms.

The group generates revenue primarily from product sales to healthcare systems, pharmacies, retailers, farmers and agricultural distributors. It complements this with digital and data‑driven services in agriculture and radiology, as well as occasional licensing and partnership income. Customers span hospitals and clinicians, consumers via retail channels, and commercial farming operations worldwide.